Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro StudyHana Oiki, Yasuhiro Tsutani|Cells|2025Cited by 1
Efficacy of Novel Third-Generation Tyrosine Kinase Inhibitors for Uncommon <em>EGFR</em> Mutations – an In Vitro StudyHana Oiki, Yasuhiro Tsutani|Preprints.org|2025Cited by 0